A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants
Recruiting
Observational Study
Cryptosporidiosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 6 Months – 59 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Age 6 months to 59 months with diarrhea according to the World Health Organization (WHO) criteria (≥3 loose stools daily for at least 2 days)
* QuikChek™ and Stool microscopy positive for Cryptosporidium at screening
* Acute (\<7 days), prolonged (lasting 7-13 days), persisten…
Contacts
Novartis Pharmaceuticals
CONTACT